×
About 111,702 results

ALLMedicine™ Rheumatoid Arthritis Center

Research & Reviews  49,539 results

Stakeholder views of podiatry services in the UK for people living with arthritis: a qu...
https://doi.org/10.1186/s13047-020-00427-7
Journal of Foot and Ankle Research; Dando C, Bacon D et. al.

Sep 25th, 2020 - The aim of this study was to explore the views of stakeholders in podiatry services, patients, commissioners and general practitioners (GP), to further understand experiences of referral, access and provision of treatment in the National Health Se...

Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis...
https://doi.org/10.1186/s13075-020-02315-8
Arthritis Research & Therapy; Min HK, Won JY et. al.

Sep 25th, 2020 - The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). Serum from patients with RA and...

"A Necessary Investment in Future Health": Perceptions of Physical Activity Maintenance...
https://doi.org/10.1093/ptj/pzaa176
Physical Therapy; Swärdh E, Nordgren B et. al.

Sep 25th, 2020 - A few studies with a qualitative design have addressed physical activity (PA) maintenance in people with rheumatoid arthritis (RA), but none of them focused specifically on maintenance of PA according to public health recommendations. The purpose ...

Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheuma...
https://doi.org/10.1111/1756-185X.13975
International Journal of Rheumatic Diseases REFERENCES; Sandoughi M, Kaykhaei MA et. al.

Sep 25th, 2020 - Chronic inflammation and subsequent use of glucocorticoids can lead to relative adrenocortical insufficiency in patients with rheumatoid arthritis (RA). Previously, adrenocortical hormone, dehydroepiandrosterone (DHEA) was shown as a potential the...

Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3...
https://doi.org/10.1007/s00198-020-05641-4
Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA; Brance ML, Pons-Estel BA et. al.

Sep 25th, 2020 - Rheumatoid arthritis (RA) patients had a higher risk of developing low bone mineral density (BMD) or osteoporosis. RA patients on classic disease-modifying antirheumatic drug (c-DMARD) therapy showed significantly lower BMD than controls, while no...

see more →

Guidelines  215 results

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
https://pubmed.ncbi.nlm.nih.gov/32796683/
Cells Massalska M

Aug 10th, 2020 - The development of biological disease-modifying antirheumatic drugs (bDMARDs) and target synthetic DMARDs (tsDMARDs), also known as small molecule inhibitors, represent a breakthrough in rheumatoid arthritis (RA) treatment. The tsDMARDs are a larg...

Study of Factors Influencing Dry Eye in Rheumatoid Arthritis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429800/
Journal of Ophthalmology; Ma W

Aug 7th, 2020 - The present study investigated the relationship between dry eye and the disease activity in patients with rheumatoid arthritis (RA).

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?’ by Marques et al
https://ard.bmj.com/content/early/2020/07/12/annrheumdis-2020-218431
Annals of Rheumatic Diseases; D'Silva DM

Jul 12th, 2020 - We appreciate the comments by Marques et al in response to our manuscript. Their description of a cohort of patients with rheumatic disease and COVID-19 is another important contribution to the literature during this quickly evolving pandemic. In ...

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
https://www.nejm.org/doi/full/10.1056/NEJMc2009567?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub 0pubmed
New England Journal of Medicine;

Jul 1st, 2020 - Data on Covid-19 in patients with immune-mediated inflammatory disease who have received anticytokine biologics, other immunomodulatory therapies, or both on a long-term basis are scarce. Trials to assess the efficacy of antirheumatic therapies su...

see more →

Drugs  2,945 results see all →

Clinicaltrials.gov  54,577 results

Stakeholder views of podiatry services in the UK for people living with arthritis: a qu...
https://doi.org/10.1186/s13047-020-00427-7
Journal of Foot and Ankle Research; Dando C, Bacon D et. al.

Sep 25th, 2020 - The aim of this study was to explore the views of stakeholders in podiatry services, patients, commissioners and general practitioners (GP), to further understand experiences of referral, access and provision of treatment in the National Health Se...

Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis...
https://doi.org/10.1186/s13075-020-02315-8
Arthritis Research & Therapy; Min HK, Won JY et. al.

Sep 25th, 2020 - The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). Serum from patients with RA and...

"A Necessary Investment in Future Health": Perceptions of Physical Activity Maintenance...
https://doi.org/10.1093/ptj/pzaa176
Physical Therapy; Swärdh E, Nordgren B et. al.

Sep 25th, 2020 - A few studies with a qualitative design have addressed physical activity (PA) maintenance in people with rheumatoid arthritis (RA), but none of them focused specifically on maintenance of PA according to public health recommendations. The purpose ...

Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheuma...
https://doi.org/10.1111/1756-185X.13975
International Journal of Rheumatic Diseases REFERENCES; Sandoughi M, Kaykhaei MA et. al.

Sep 25th, 2020 - Chronic inflammation and subsequent use of glucocorticoids can lead to relative adrenocortical insufficiency in patients with rheumatoid arthritis (RA). Previously, adrenocortical hormone, dehydroepiandrosterone (DHEA) was shown as a potential the...

Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3...
https://doi.org/10.1007/s00198-020-05641-4
Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA; Brance ML, Pons-Estel BA et. al.

Sep 25th, 2020 - Rheumatoid arthritis (RA) patients had a higher risk of developing low bone mineral density (BMD) or osteoporosis. RA patients on classic disease-modifying antirheumatic drug (c-DMARD) therapy showed significantly lower BMD than controls, while no...

see more →

News  4,271 results

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
https://pubmed.ncbi.nlm.nih.gov/32796683/
Cells Massalska M

Aug 10th, 2020 - The development of biological disease-modifying antirheumatic drugs (bDMARDs) and target synthetic DMARDs (tsDMARDs), also known as small molecule inhibitors, represent a breakthrough in rheumatoid arthritis (RA) treatment. The tsDMARDs are a larg...

Study of Factors Influencing Dry Eye in Rheumatoid Arthritis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429800/
Journal of Ophthalmology; Ma W

Aug 7th, 2020 - The present study investigated the relationship between dry eye and the disease activity in patients with rheumatoid arthritis (RA).

Risk of incident type 2 diabetes among patients with rheumatoid arthritis: a population‐based cohort study
https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24343
Arthritis Care & Research; Jin Y

Aug 2nd, 2020 - We examined risk of incident type 2 diabetes mellitus (T2DM) among RA patients versus four different comparison cohorts.

Response to: ‘COVID-19 in patients with rheumatic diseases: what is the real mortality risk?’ by Marques et al
https://ard.bmj.com/content/early/2020/07/12/annrheumdis-2020-218431
Annals of Rheumatic Diseases; D'Silva DM

Jul 12th, 2020 - We appreciate the comments by Marques et al in response to our manuscript. Their description of a cohort of patients with rheumatic disease and COVID-19 is another important contribution to the literature during this quickly evolving pandemic. In ...

Regeneron, Sanofi arthritis drug fails COVID-19 study
https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms/regeneron-sanofi-arthritis-drug-fails-covid-19-study-idUSKBN24337U

Jul 2nd, 2020 - FILE PHOTO: The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to ...

see more →

Patient Education  155 results see all →